AVB-401

N/A

Report date: 2025/07/07 15:50:06

Base Information

Drug NameAVB-401
Drug Alias NameAVB-401AVB-401 BAG3 DCMSGT-401
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionBAG3 gene transference
TargetsBAG family molecular chaperone regulator 3
Therapy Area/IndicationsCardiomyopathy, Dilated
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAavantiBio Inc
China Registration ClassN/A

Develop Information

Active CompaniesSolid Biosciences IncAavantiBio IncRocket Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsCardiomyopathy, Dilated
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A